| OA20.05 | HIV-1 infection and the control of viral replication are associated with greater expression of interleukin-21 receptor on CD8+ T cells | Oral Abstract Session | Cellular immunity |
| OA21.01 | Effect of navigation services to achieve viral suppression among men who have sex with men (MSM) and transwomen living with HIV who attend public HIV care services in Lima, Peru | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA21.02 | Methadone program participation and current ART use among people who inject drugs in Kenya | Oral Abstract Session | Discovery and evaluation of biomedical agents |
| OA21.03 | Using an HIV risk assessment tool to increase frequency of HIV testing in men who have sex with men in Beijing, China: an app-based randomized, controlled trial | Oral Abstract Session | Clinical trial results |
| OA21.04 | Peer-distributed HIV self-test kits to increase demand for HIV prevention and care services in rural KwaZulu-Natal, South Africa: a three-armed cluster-randomised trial comparing social-networks versus direct delivery | Oral Abstract Session | Clinical trial results |
| OA21.05LB | Partners support, disclosure and side effects: facilitators of high maternal PrEP adherence in Cape Town, South Africa | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA22.01 | R5 tropic HIV-1 is preferentially translocated of across genital mucosa while X4 tropic HIV-1 is selectively sequestered in genital epithelial cells and activates type I IFN signaling | Oral Abstract Session | Transmission of HIV |
| OA22.02 | Dynamics of mucosal immune responses elicited by systemic prime/boost vaccination | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA22.03 | Temporal and spatial characterization of SIV infection dynamics in rhesus macaque mucosal tissues | Oral Abstract Session | Mucosal immunity |
| OA22.04 | Immune oscillatory nature through menstrual cycle regulation drives SHIV susceptibility from vaginal challenge | Oral Abstract Session | Microbiome & STI: impact on prevention |